[PDF][PDF] Contribution of MASK-air® as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma

B Sousa-Pinto, JA Fonseca, J Bousquet - J Investig Allergol Clin Immunol, 2024 - jiaci.org
In chronic diseases, mobile health apps may help to (i) improve clinical management and (ii)
provide valuable real-world scientific evidence. In allergic rhinitis, a market research study …

[HTML][HTML] Airway barriers during inflammatory diseases: discovery of genome-based alterations by using next-generation sequencing

T Hanif - 2024 - helda.helsinki.fi
Inflammatory upper airway diseases are prevalent worldwide and can lead to functional
impairment in patients. However, their effects on upper airway gene expression remain …

Is the new ARIA classification of rhinitis impacting our practice?

J Bousquet, JM Anto, B Sousa-Pinto, M Savouré… - Allergo Journal, 2024 - Springer
Paradigm shift in rhinitis and asthma multimorbidity: Asthma (A), rhinitis (R) and atopic
dermatitis (AD) are interrelated clinical phenotypes that partly overlap in the human …

Allergologie im Kloster 2024–Kloster Eberbach, Eltville/Rheingau, 3. und 4. Mai 2024

L Klimek - Allergologie, 2024 - search.proquest.com
Einleitung: Die Pharmakotherapie ist die wesentliche Säule in der Behandlung der
allergischen Rhinitis. Während Antihistaminika und intranasale Glukokortikosteroide (INCS) …